Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Drappatz

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Nature Medicine|January 16, 2026
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trialPriscilla K Brastianos, Katharine Dooley, Susan Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform TrialPatrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Cancer Discovery|May 17, 2012
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitorsIgor Vivanco, H Ian Robins, Daniel Rohle, et al.
Journal of Neuro-Oncology|March 1, 2024
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumorsJames L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Neuro-Oncology|March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastomaPatrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Blood|January 6, 2025
Glucarpidase for treatment of high-dose methotrexate toxicityShruti Gupta, Sarah A Kaunfer, Kevin L Chen, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Nature Medicine|January 16, 2026
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trialPriscilla K Brastianos, Katharine Dooley, Susan Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform TrialPatrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Cancer Discovery|May 17, 2012
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitorsIgor Vivanco, H Ian Robins, Daniel Rohle, et al.
Journal of Neuro-Oncology|March 1, 2024
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumorsJames L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive RandomizationRifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Neuro-Oncology|March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastomaPatrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Blood|January 6, 2025
Glucarpidase for treatment of high-dose methotrexate toxicityShruti Gupta, Sarah A Kaunfer, Kevin L Chen, et al.
Pageof 12